from
Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis
Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis
Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the…

